HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Cognis Acquisition Would Reinforce BASF's Personal-Care Portfolio

This article was originally published in The Rose Sheet

Executive Summary

Already one of the world's largest chemical companies, BASF is reportedly close to a deal to acquire fellow German supplier Cognis

You may also be interested in...



BASF's Cognis Acquisition Creates Preeminent Personal-Care Portfolio

BASF's June 23 acquisition of Cognis will make it the global leader in personal-care ingredients and the only supplier "capable of offering a full range of ingredients" in the segment, the firm says

BASF's Cognis Acquisition Creates Preeminent Personal-Care Portfolio

BASF's June 23 acquisition of Cognis will make it the global leader in personal-care ingredients and the only supplier "capable of offering a full range of ingredients" in the segment, the firm says

Henkel closes Cognis sale

Consumer products manufacturer completed the sale of its Cognis chemical business in a transaction valued at $2.2 bil., the company announces Nov. 30. Henkel said it would sell its chemical business to focus on strengthening its existing consumer products and industrial services businesses (1"The Rose Sheet" Nov. 19, p. 11). Cognis was purchased by a consortium of investors led by Permira...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS016969

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel